Clinical Trial Update: A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing budesonide/formoterol fumarate metered-dose inhaler to budesonide metered-dose inhaler in adults with inadequately controlled asthma c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide Metered Dose Inhaler (budesonide)
• Budesonide and Formoterol Fumarate Metered Dose Inhaler (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2026-01-28